Yuko Kuboki

1.1k total citations
15 papers, 696 citations indexed

About

Yuko Kuboki is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Yuko Kuboki has authored 15 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Yuko Kuboki's work include Pancreatic and Hepatic Oncology Research (13 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Genomics and Diagnostics (5 papers). Yuko Kuboki is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Genomics and Diagnostics (5 papers). Yuko Kuboki collaborates with scholars based in Japan and United States. Yuko Kuboki's co-authors include Toru Furukawa, Keiko Shiratori, Takashi Hatori, Masakazu Yamamoto, Noriyuki Shibata, Kyoko Shimizu, Etsuko Tanji, Shoko Yoshida, Naoyuki Kamatani and Hiroshi Yamaguchi and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Molecular Cancer.

In The Last Decade

Yuko Kuboki

13 papers receiving 691 citations

Peers

Countries citing papers authored by Yuko Kuboki

Since Specialization

Citations

This map shows the geographic impact of Yuko Kuboki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Kuboki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Kuboki more than expected).

Fields of papers citing papers by Yuko Kuboki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Kuboki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Kuboki. The network helps show where Yuko Kuboki may publish in the future.

Co-authorship network of co-authors of Yuko Kuboki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Kuboki. A scholar is included among the top collaborators of Yuko Kuboki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Kuboki. Yuko Kuboki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers 2025 ·ESMO Open ·Steven B. Maron, Keisho Chìn, Fadi S. Braiteh, Seiichiro Mitani, (unknown), Yuko Kuboki, Mary F. Mulcahy, Joaquina Baranda, (unknown), Ning Jin, Satoshi Hamauchi, Jason Kaplan, Seema Rao Gorla, Sheng Liu, Marcin Woźniak, (unknown), (unknown), Changting Meng, Soichiro Kondo	0
2	608O Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC) 2024 ·Annals of Oncology ·Wungki Park, Anup Kasi, Alexander I. Spira, Jordan Berlin, (unknown), (unknown), Yuko Kuboki, Shigehisa Kitano, (unknown), (unknown), (unknown), Soichiro Kondo, (unknown), Hisaki Fujii, Heon‐Jeong Lee, Stanley C. Gill, Abdel Saci, (unknown), Anthony W. Tolcher	15
3	Aspartate racemase and d-aspartate in starfish; possible involvement in testicular maturation 2019 ·Bioscience Biotechnology and Biochemistry ·(unknown), (unknown), Yuko Kuboki, Hiroko Matsuda, Katsumasa Abe, Shouji Takahashi, Yoshio Kera	2
4	AB113. P087. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions 2018 ·Yuko Kuboki, (unknown), (unknown), Wenjie Huang, Jun Yu, Peter Chianchiano, Waki Hosoda, Lily Zheng, Xiaoshan M. Shao, Elizabeth Thompson, Kevin Waters, Justin Poling, (unknown), Matthew J. Weiss, Christopher L. Wolfgang, Michael Goggins, Ralph H. Hruban, Nicholas J. Roberts, Rachel Karchin, Laura D. Wood	1
5	Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas 2015 ·Scientific Reports ·Toru Furukawa, Hitomi Sakamoto, Shoko Takeuchi, (unknown), Yuko Kuboki, Toshiyuki Yamamoto, Takashi Hatori, Masakazu Yamamoto, Masanori Sugiyama, Nobuyuki Ohike, Hiroshi Yamaguchi, (unknown), Noriyuki Shibata, Kyoko Shimizu, Keiko Shiratori	74
6	Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas 2014 ·Modern Pathology ·Hitomi Sakamoto, Yuko Kuboki, Takashi Hatori, Masakazu Yamamoto, Masanori Sugiyama, Noriyuki Shibata, Kyoko Shimizu, Keiko Shiratori, Toru Furukawa	54
7	Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas 2014 ·Pancreas ·Yuko Kuboki, Kyoko Shimizu, Takashi Hatori, Masakazu Yamamoto, Noriyuki Shibata, Keiko Shiratori, Toru Furukawa	67
8	The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant 2013 ·The Journal of Pathology ·Hiroshi Yamaguchi, Yuko Kuboki, Takashi Hatori, Masakazu Yamamoto, Kyoko Shimizu, Keiko Shiratori, Noriyuki Shibata, (unknown), Toru Furukawa	52
9	Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cells 2012 ·Molecular Cancer ·Toru Furukawa, Etsuko Tanji, Yuko Kuboki, Takashi Hatori, Masakazu Yamamoto, Kyoko Shimizu, Noriyuki Shibata, Keiko Shiratori	18
10	Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation 2012 ·Clinical Journal of Gastroenterology ·(unknown), Yoshiki Naito, (unknown), Yoshihiro Izumi, (unknown), (unknown), Akiko Sasaki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Seiji Fukuda, Hiroshi Yamaguchi, Yuko Kuboki, Toru Furukawa, Michio Hifumi	15
11	Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms 2011 ·The Journal of Pathology ·Hong Xiao, Hiroshi Yamaguchi, Dora Dias‐Santagata, Yuko Kuboki, Sara Akhavanfard, Takashi Hatori, Masakazu Yamamoto, Keiko Shiratori, Makio Kobayashi, (unknown), Carlos Fernández‐del Castillo, Mari Mino–Kenudson, Toru Furukawa	48
12	Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas 2011 ·Scientific Reports ·Toru Furukawa, Yuko Kuboki, Etsuko Tanji, Shoko Yoshida, Takashi Hatori, Masakazu Yamamoto, Noriyuki Shibata, Kyoko Shimizu, Naoyuki Kamatani, Keiko Shiratori	323
13	Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas 2010 ·Modern Pathology ·Yuko Kuboki, Keiko Shiratori, Takashi Hatori, Izumi Fujita, (unknown), Masakazu Yamamoto, Makio Kobayashi, Toru Furukawa	18
14	Noninvasive and Minimally Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas 2010 ·Pathology Case Reviews ·Toru Furukawa, Takashi Hatori, (unknown), Yuko Kuboki, (unknown), (unknown), (unknown), Kyoko Shimizu, (unknown), Makio Kobayashi, Masakazu Yamamoto, Keiko Shiratori	1
15	A Case of Solid Pseudopapillary Neoplasm of the Pancreas Presenting with Left-sided Extrahepatic Portal Hypertension 2010 ·Internal Medicine ·Shinichi Nakamura, (unknown), Yuko Kuboki, (unknown), (unknown), Hiroyuki Konishi, Takashi Hatori, Toru Furukawa, Keiko Shiratori	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact